ESMO® 2026 Highlights: Presenter Vignettes – Kazuki Nozawa

Dr. Kazuki Nozawa

Kazuki Nozawa

MD

Nagoya City University

1770RO

Ultra-sensitive MRD Assessment in Long-term Complete Responders to Anti-HER2 Therapy in HER2-positive Metastatic Breast Cancer: Initial Results from HER2-CR Study